This inventor holds 1 USPTO granted patent. Top assignees: Cerva-Coda, Institut Scientifique De Sante Publique, Université De Mons. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Virginie Roupie: Innovator in Paratuberculosis Diagnosis and Vaccination
Introduction
Virginie Roupie is a notable inventor based in Court-Saint-Etienne, Belgium. She has made significant contributions to the field of veterinary medicine, particularly in the diagnosis and vaccination against paratuberculosis. Her innovative work has implications not only for livestock but also for human health.
Latest Patents
Virginie Roupie holds a patent for "Antigens for paratuberculosis diagnosis and vaccination." This invention discloses new antigens of the subsp., along with antigenic compositions that comprise at least two of these antigens. The patent also includes epitopes, antibodies, or hypervariable fragments thereof, as well as nucleotide sequences coding for them. The invention is aimed at improving diagnosis and vaccination against subsp. in mammals, particularly in cattle, sheep, and caprines. Additionally, it explores potential applications in diagnosing and vaccinating against Crohn's disease in humans.
Career Highlights
Throughout her career, Virginie Roupie has worked with various organizations, including Cerva-Coda and the Institut Scientifique de Santé Publique. Her work has been instrumental in advancing the understanding and treatment of paratuberculosis.
Collaborations
Virginie has collaborated with notable individuals in her field, including Baptiste Leroy and Christiane A J Huygen. These collaborations have further enriched her research and contributions to veterinary medicine.
Conclusion
Virginie Roupie's innovative work in the field of paratuberculosis diagnosis and vaccination highlights her commitment to improving animal health and has potential benefits for human health as well. Her contributions are a testament to the importance of innovation in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile